18 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33393497 | Insulin signaling in health and disease. | 2021 Jan 4 | 1 |
2 | 33888713 | Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer. | 2021 Apr 22 | 1 |
3 | 31600013 | Distinct roles of PIK3CA in the enrichment and maintenance of cancer stem cells in head and neck squamous cell carcinoma. | 2020 Jan | 1 |
4 | 31611073 | Class I phosphoinositide 3-kinase (PI3K) regulatory subunits and their roles in signaling and disease. | 2020 Jan | 1 |
5 | 32049032 | Allosteric Activation of PI3Kα Results in Dynamic Access to Catalytically Competent Conformations. | 2020 Apr 7 | 2 |
6 | 28462395 | Calmodulin and PI3K Signaling in KRAS Cancers. | 2017 Mar | 2 |
7 | 29211993 | Single-Molecule Study Reveals How Receptor and Ras Synergistically Activate PI3Kα and PIP3 Signaling. | 2017 Dec 5 | 1 |
8 | 26267517 | Activating Mutations in PIK3CA Lead to Widespread Modulation of the Tyrosine Phosphoproteome. | 2015 Sep 4 | 1 |
9 | 25309634 | Activation of PI3Kα by physiological effectors and by oncogenic mutations: structural and dynamic effects. | 2014 Mar 1 | 2 |
10 | 21788516 | Essential role of Stat3 in PI3K-induced oncogenic transformation. | 2011 Aug 9 | 1 |
11 | 20308428 | The PI3K p110alpha isoform regulates endothelial adherens junctions via Pyk2 and Rac1. | 2010 Mar 22 | 1 |
12 | 20593314 | Structural effects of oncogenic PI3Kα mutations. | 2010 | 1 |
13 | 17452978 | KIT oncoprotein interactions in gastrointestinal stromal tumors: therapeutic relevance. | 2007 Sep 27 | 1 |
14 | 12213328 | Defective CD19-dependent signaling in B-1a and B-1b B lymphocyte subpopulations. | 2002 Sep | 1 |
15 | 11368773 | Mapping the Zap-70 phosphorylation sites on LAT (linker for activation of T cells) required for recruitment and activation of signalling proteins in T cells. | 2001 Jun 1 | 1 |
16 | 10488146 | JAK1-dependent phosphorylation of insulin receptor substrate-1 (IRS-1) is inhibited by IRS-1 serine phosphorylation. | 1999 Sep 24 | 1 |
17 | 9446654 | The p85 and p110 subunits of phosphatidylinositol 3-kinase-alpha are substrates, in vitro, for a constitutively associated protein tyrosine kinase in platelets. | 1998 Feb 1 | 1 |
18 | 7492761 | Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin. | 1995 Dec 1 | 1 |